RIVA-HYDROXYUREA
Identification of Riva-Hydroxyurea
| No description |
Google image searchProduct monograph
Active ingredient
hydroxyurea, 500 MG
DIN: 02530260
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: LABORATOIRE RIVA INC.
Date: 01-MAY-2023
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01X — OTHER ANTINEOPLASTIC AGENTS (ATC, ATC/DDD)
- L01XX — Other antineoplastic agents (ATC, ATC/DDD)
- L01XX05 — HYDROXYCARBAMIDE (ATC/DDD)
Reference brand drug: Hydrea
Pharmaceutical standard: USP
